AccuStem Sciences, Inc.
ACUT
$0.388
$0.11240.58%
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -72.95% | 61.53% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -58.90% | 60.54% | |||
| Operating Income | 58.90% | -60.54% | |||
| Income Before Tax | 58.90% | -60.54% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 58.90% | -60.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 58.90% | -60.54% | |||
| EBIT | 58.90% | -60.54% | |||
| EBITDA | 58.99% | -60.73% | |||
| EPS Basic | 58.82% | -60.18% | |||
| Normalized Basic EPS | 58.79% | -60.98% | |||
| EPS Diluted | 58.82% | -60.18% | |||
| Normalized Diluted EPS | 58.79% | -60.98% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
